{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:39:05Z","timestamp":1792654745195,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"DOI":"10.1007\/s11910-026-01532-z","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:56:31Z","timestamp":1792652191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["When to Start Oral Anticoagulant Therapy Post-Stroke: From Common to Rare Conundrums"],"prefix":"10.1007","volume":"26","author":[{"given":"Hrvoje","family":"Budin\u010devi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u010crnac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrija","family":"Me\u0161trovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Ernoi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Vogrinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj Mark","family":"Poje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Ze\u010devi\u0107","family":"Peni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vujovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"9913","key":"1532_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245\u201354. https:\/\/doi.org\/10.1016\/s0140-6736(13)61953-4.","journal-title":"Lancet"},{"issue":"4","key":"1532_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1177\/23969873251337666","volume":"10","author":"JJ McCabe","year":"2025","unstructured":"McCabe JJ, Brennan SO. Anticoagulation in atrial fibrillation detected after stroke: Many questions, some answers. Eur Stroke J. 2025;10(4):1231\u20132. https:\/\/doi.org\/10.1177\/23969873251337666.","journal-title":"Eur Stroke J"},{"issue":"12","key":"1532_CR3","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/hs1201.100209","volume":"32","author":"PL Kolominsky-Rabas","year":"2001","unstructured":"Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735\u201340. https:\/\/doi.org\/10.1161\/hs1201.100209.","journal-title":"Stroke"},{"issue":"10","key":"1532_CR4","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/europace\/euq350","volume":"12","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360\u2013420. https:\/\/doi.org\/10.1093\/europace\/euq350.","journal-title":"Europace"},{"issue":"7","key":"1532_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492\u2013501. https:\/\/doi.org\/10.7326\/0003-4819-131-7-199910050-00003.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1532_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4065\/mcp.2009.0278","volume":"84","author":"TP Moyer","year":"2009","unstructured":"Moyer TP, O\u2019Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, et al. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc. 2009;84(12):1079\u201394. https:\/\/doi.org\/10.4065\/mcp.2009.0278.","journal-title":"Mayo Clin Proc"},{"issue":"2 Suppl 1","key":"1532_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1714\/4419.44150","volume":"26","author":"IC Van Gelder","year":"2025","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJ, et al. [2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol. (Rome). 2025;26(2 Suppl 1):e1\u2013104. https:\/\/doi.org\/10.1714\/4419.44150.","journal-title":"(Rome)"},{"issue":"1","key":"1532_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1\u2013156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation"},{"issue":"3","key":"1532_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn CJ, Paciaroni M, Berge E, Korompoki E, Korv J, Lal A, et al. Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline. Eur Stroke J. 2019;4(3):198\u2013223. https:\/\/doi.org\/10.1177\/2396987319841187.","journal-title":"Eur Stroke J"},{"issue":"8","key":"1532_CR10","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1161\/STR.0000000000000513","volume":"57","author":"S Prabhakaran","year":"2026","unstructured":"Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2026;57(8):e316\u2013436. https:\/\/doi.org\/10.1161\/STR.0000000000000513.","journal-title":"Stroke"},{"issue":"10","key":"1532_CR11","doi-asserted-by":"publisher","first-page":"CD000024","DOI":"10.1002\/14651858.CD000024.pub5","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang X, Ouyang M, Yang J, Song L, Yang M, Anderson CS. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2021;10(10):CD000024. https:\/\/doi.org\/10.1002\/14651858.CD000024.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1532_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/2396987317719364","volume":"2","author":"JM Ferro","year":"2017","unstructured":"Ferro JM, Bousser MG, Canhao P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195\u2013221. https:\/\/doi.org\/10.1177\/2396987317719364.","journal-title":"Eur Stroke J"},{"issue":"1","key":"1532_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","volume":"65","author":"R Naylor","year":"2023","unstructured":"Naylor R, Rantner B, Ancetti S, de Borst GJ, De Carlo M, Halliday A, et al. Editor\u2019s Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. Eur J Vasc Endovasc Surg. 2023;65(1):7\u2013111. https:\/\/doi.org\/10.1016\/j.ejvs.2022.04.011.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2\u20134","key":"1532_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/CH-2010-1314","volume":"45","author":"B Leithauser","year":"2010","unstructured":"Leithauser B, Jung F, Park JW. Rheological and hemostasiological aspects of thrombus formation in the left atrial appendage in atrial fibrillation? A new strategy for prevention of cardioembolic stroke. Clin Hemorheol Microcirc. 2010;45(2\u20134):311\u201323. https:\/\/doi.org\/10.3233\/CH-2010-1314.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"19","key":"1532_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","volume":"106","author":"WY Ding","year":"2020","unstructured":"Ding WY, Gupta D, Lip GYH. Atrial fibrillation and the prothrombotic state: revisiting Virchow\u2019s triad in 2020. Heart. 2020;106(19):1463\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2020-316977.","journal-title":"Heart"},{"issue":"9658","key":"1532_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","volume":"373","author":"T Watson","year":"2009","unstructured":"Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited. Lancet. 2009;373(9658):155\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(09)60040-4.","journal-title":"Lancet"},{"issue":"3","key":"1532_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/157340310791658730","volume":"6","author":"A Arboix","year":"2010","unstructured":"Arboix A, Alio J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6(3):150\u201361. https:\/\/doi.org\/10.2174\/157340310791658730.","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"1532_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/01.str.21.7.1000","volume":"21","author":"M Yasaka","year":"1990","unstructured":"Yasaka M, Yamaguchi T, Miyashita T, Park YD, Sawada T, Omae T. Predisposing factors of recurrent embolization in cardiogenic cerebral embolism. Stroke. 1990;21(7):1000\u20137. https:\/\/doi.org\/10.1161\/01.str.21.7.1000.","journal-title":"Stroke"},{"key":"1532_CR19","unstructured":"Ibrahim F, Murr NI. Embolic Stroke. StatPearls. Treasure Island (FL)2026."},{"issue":"12","key":"1532_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/01.str.19.12.1482","volume":"19","author":"J Lodder","year":"1988","unstructured":"Lodder J, Krijne-Kubat B, van der Lugt PJ. Timing of autopsy-confirmed hemorrhagic infarction with reference to cardioembolic stroke. Stroke. 1988;19(12):1482\u20134. https:\/\/doi.org\/10.1161\/01.str.19.12.1482.","journal-title":"Stroke"},{"key":"1532_CR21","doi-asserted-by":"publisher","first-page":"4244267","DOI":"10.1155\/2021\/4244267","volume":"2021","author":"SE Thomas","year":"2021","unstructured":"Thomas SE, Plumber N, Venkatapathappa P, Gorantla V. A Review of Risk Factors and Predictors for Hemorrhagic Transformation in Patients with Acute Ischemic Stroke. Int J Vasc Med. 2021;2021:4244267. https:\/\/doi.org\/10.1155\/2021\/4244267.","journal-title":"Int J Vasc Med"},{"key":"1532_CR22","doi-asserted-by":"publisher","unstructured":"Honig A, Percy J, Sepehry AA, Gomez AG, Field TS, Benavente OR. Hemorrhagic Transformation in Acute Ischemic Stroke: A Quantitative Systematic Review. J Clin Med. 2022;11(5). https:\/\/doi.org\/10.3390\/jcm11051162.","DOI":"10.3390\/jcm11051162"},{"issue":"3","key":"1532_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/NRL.0000000000000462","volume":"28","author":"E Grifoni","year":"2023","unstructured":"Grifoni E, Bini C, Signorini I, Cosentino E, Micheletti I, Dei A, et al. Predictive Factors for Hemorrhagic Transformation in Acute Ischemic Stroke in the REAL-World Clinical Practice. Neurologist. 2023;28(3):150\u20136. https:\/\/doi.org\/10.1097\/NRL.0000000000000462.","journal-title":"Neurologist"},{"issue":"3","key":"1532_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3988\/jcn.2006.2.3.163","volume":"2","author":"HY Kim","year":"2006","unstructured":"Kim HY, Han SH. Matrix metalloproteinases in cerebral ischemia. J Clin Neurol. 2006;2(3):163\u201370. https:\/\/doi.org\/10.3988\/jcn.2006.2.3.163.","journal-title":"J Clin Neurol"},{"issue":"2","key":"1532_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","volume":"34","author":"GC Jickling","year":"2014","unstructured":"Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34(2):185\u201399. https:\/\/doi.org\/10.1038\/jcbfm.2013.203.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"1532_CR26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/STROKEAHA.110.604652","volume":"42","author":"W Pfeilschifter","year":"2011","unstructured":"Pfeilschifter W, Spitzer D, Czech-Zechmeister B, Steinmetz H, Foerch C. Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice. Stroke. 2011;42(4):1116\u201321. https:\/\/doi.org\/10.1161\/STROKEAHA.110.604652.","journal-title":"Stroke"},{"issue":"22","key":"1532_CR27","doi-asserted-by":"publisher","first-page":"e010133","DOI":"10.1161\/JAHA.118.010133","volume":"7","author":"M Paciaroni","year":"2018","unstructured":"Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, et al. Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes. J Am Heart Assoc. 2018;7(22):e010133. https:\/\/doi.org\/10.1161\/JAHA.118.010133.","journal-title":"J Am Heart Assoc"},{"issue":"2 Suppl","key":"1532_CR28","doi-asserted-by":"publisher","first-page":"eS44","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):eS44\u201388. https:\/\/doi.org\/10.1378\/chest.11-2292.","journal-title":"Chest"},{"issue":"4","key":"1532_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/10409238.2015.1050550","volume":"50","author":"SA Smith","year":"2015","unstructured":"Smith SA, Travers RJ, Morrissey JH. How it all starts: Initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 2015;50(4):326\u201336. https:\/\/doi.org\/10.3109\/10409238.2015.1050550.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1532_CR30","doi-asserted-by":"publisher","first-page":"110192","DOI":"10.1016\/j.neuropharm.2024.110192","volume":"262","author":"H Kawa","year":"2025","unstructured":"Kawa H, Ahmed Z, Majid A, Chen R. Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow? Neuropharmacology. 2025;262:110192. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110192.","journal-title":"Neuropharmacology"},{"issue":"13","key":"1532_CR31","doi-asserted-by":"publisher","first-page":"e1143","DOI":"10.1212\/WNL.0000000000005207","volume":"90","author":"R Kurogi","year":"2018","unstructured":"Kurogi R, Nishimura K, Nakai M, Kada A, Kamitani S, Nakagawara J, et al. Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin. Neurology. 2018;90(13):e1143\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000005207.","journal-title":"Neurology"},{"key":"1532_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02197-4","author":"DJ Werring","year":"2024","unstructured":"Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, et al. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial. Lancet. 2024. https:\/\/doi.org\/10.1016\/S0140-6736(24)02197-4.","journal-title":"Lancet"},{"issue":"6","key":"1532_CR33","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/STROKEAHA.125.055037","volume":"57","author":"J Lyon","year":"2026","unstructured":"Lyon J, Nash PS, Ahmed N, Aram L, Balogun M, Bennett K, et al. Early Versus Delayed Anticoagulation in Acute Ischemic Stroke According to Atrial Fibrillation Subtype and Time of Diagnosis: Subgroup Analysis of the OPTIMAS Randomized Controlled Trial. Stroke. 2026;57(6):1513\u201325. https:\/\/doi.org\/10.1161\/STROKEAHA.125.055037.","journal-title":"Stroke"},{"issue":"7","key":"1532_CR34","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/17474930261441297","volume":"21","author":"PS Nash","year":"2026","unstructured":"Nash PS, Best JG, Lyon J, Ruffle JK, Amornpojnimman T, Mendel R, et al. Early versus delayed anticoagulation in acute ischemic stroke with atrial fibrillation according to infarct volume and location: A prespecified subgroup analysis of the OPTIMAS randomized controlled trial. Int J Stroke. 2026;21(7):956\u201367. https:\/\/doi.org\/10.1177\/17474930261441297.","journal-title":"Int J Stroke"},{"issue":"8","key":"1532_CR35","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1161\/STROKEAHA.125.051457","volume":"56","author":"PS Nash","year":"2025","unstructured":"Nash PS, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, et al. Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial. Stroke. 2025;56(8):1970\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.125.051457.","journal-title":"Stroke"},{"issue":"14","key":"1532_CR36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","volume":"146","author":"J Oldgren","year":"2022","unstructured":"Oldgren J, Asberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B, et al. Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study. Circulation. 2022;146(14):1056\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060666.","journal-title":"Circulation"},{"key":"1532_CR37","doi-asserted-by":"publisher","unstructured":"Fasth O, Oldgren J, Ghukasyan Lakic T, Hijazi Z, Norrving B, Wester P, et al. Early versus delayed DOAC after ischaemic stroke in atrial fibrillation: 1-year outcomes in the TIMING study and in concurrent practice. Eur Stroke J. 2026;11(2). https:\/\/doi.org\/10.1093\/esj\/aakag010.","DOI":"10.1093\/esj\/aakag010"},{"issue":"26","key":"1532_CR38","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, et al. Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. N Engl J Med. 2023;388(26):2411\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2303048.","journal-title":"N Engl J Med"},{"issue":"8","key":"1532_CR39","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/STROKEAHA.125.050646","volume":"56","author":"A Wouters","year":"2025","unstructured":"Wouters A, Demeestere J, Rossel JB, Devroye A, Desfontaines P, Vanacker P, et al. Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN Trial. Stroke. 2025;56(8):2000\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.125.050646.","journal-title":"Stroke"},{"issue":"1","key":"1532_CR40","doi-asserted-by":"publisher","first-page":"e2456307","DOI":"10.1001\/jamanetworkopen.2024.56307","volume":"8","author":"AA Polymeris","year":"2025","unstructured":"Polymeris AA, Branca M, Sylaja PN, Sandset EC, de Sousa DA, Thomalla G, et al. Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. JAMA Netw Open. 2025;8(1):e2456307. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.56307.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1532_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2024.1450","volume":"81","author":"MB Goeldlin","year":"2024","unstructured":"Goeldlin MB, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, et al. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. JAMA Neurol. 2024;81(7):693\u2013702. https:\/\/doi.org\/10.1001\/jamaneurol.2024.1450.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1532_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.124.069324","volume":"150","author":"R Rohner","year":"2024","unstructured":"Rohner R, Kneihsl M, Goeldlin MB, Hakim A, Branca M, Abend S, et al. Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial. Circulation. 2024;150(1):19\u201329. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.069324.","journal-title":"Circulation"},{"issue":"1","key":"1532_CR43","doi-asserted-by":"publisher","first-page":"e210157","DOI":"10.1212\/WNL.0000000000210157","volume":"104","author":"M Kneihsl","year":"2025","unstructured":"Kneihsl M, Hakim A, Goeldlin MB, Meinel TR, Branca M, Rohner R, et al. Early vs Late Anticoagulation After Ischemic Stroke in Patients With Atrial Fibrillation and Covert Brain Infarcts. Neurology. 2025;104(1):e210157. https:\/\/doi.org\/10.1212\/WNL.0000000000210157.","journal-title":"Neurology"},{"issue":"5","key":"1532_CR44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2025.0285","volume":"82","author":"SJ Warach","year":"2025","unstructured":"Warach SJ, Davis LA, Lawrence P, Gajewski B, Wick J, Shi F, et al. Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. JAMA Neurol. 2025;82(5):470\u20136. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0285.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1532_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/svn-2023-002357","volume":"9","author":"A Sharobeam","year":"2024","unstructured":"Sharobeam A, Lin L, Lam C, Garcia-Esperon C, Gawarikar Y, Patel R, et al. Early anticoagulation in patients with stroke and atrial fibrillation is associated with fewer ischaemic lesions at 1 month: the ATTUNE study. Stroke Vasc Neurol. 2024;9(1):30\u20137. https:\/\/doi.org\/10.1136\/svn-2023-002357.","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"1532_CR46","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1038\/s41598-025-91774-7","volume":"15","author":"F Li","year":"2025","unstructured":"Li F, Liu J, Zhang F, Wu X, Dai T, Kuang J, et al. Anticoagulation therapy after reperfusion treatment for acute ischemic stroke with non-valvular atrial fibrillation: a multicenter retrospective study. Sci Rep. 2025;15(1):9619. https:\/\/doi.org\/10.1038\/s41598-025-91774-7.","journal-title":"Sci Rep"},{"key":"1532_CR47","doi-asserted-by":"publisher","unstructured":"Olma MC, Tutuncu S, Hansen K, Grittner U, Kunze C, Dietzel J, et al. Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation Registry. Open Heart. 2024;11(2). https:\/\/doi.org\/10.1136\/openhrt-2024-002688.","DOI":"10.1136\/openhrt-2024-002688"},{"issue":"10","key":"1532_CR48","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1177\/17474930231184366","volume":"18","author":"GM Grosse","year":"2023","unstructured":"Grosse GM, Husing A, Stang A, Kuklik N, Brinkmann M, Nabavi D, et al. Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study. Int J Stroke. 2023;18(10):1169\u201377. https:\/\/doi.org\/10.1177\/17474930231184366.","journal-title":"Int J Stroke"},{"issue":"2","key":"1532_CR49","doi-asserted-by":"publisher","first-page":"e0212354","DOI":"10.1371\/journal.pone.0212354","volume":"14","author":"M Yasaka","year":"2019","unstructured":"Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T, et al. Rivaroxaban administration after acute ischemic stroke: The RELAXED study. PLoS ONE. 2019;14(2):e0212354. https:\/\/doi.org\/10.1371\/journal.pone.0212354.","journal-title":"PLoS ONE"},{"issue":"4","key":"1532_CR50","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1161\/STROKEAHA.120.030042","volume":"52","author":"AJ Labovitz","year":"2021","unstructured":"Labovitz AJ, Rose DZ, Fradley MG, Meriwether JN, Renati S, Martin R, et al. Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial. Stroke. 2021;52(4):1164\u201371. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030042.","journal-title":"Stroke"},{"issue":"5","key":"1532_CR51","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00415-020-10335-2","volume":"268","author":"A Alrohimi","year":"2021","unstructured":"Alrohimi A, Buck B, Jickling G, Shuaib A, Thirunavukkarasu S, Butcher KS. Early apixaban therapy after ischemic stroke in patients with atrial fibrillation. J Neurol. 2021;268(5):1837\u201346. https:\/\/doi.org\/10.1007\/s00415-020-10335-2.","journal-title":"J Neurol"},{"issue":"3","key":"1532_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10072-025-08789-1","volume":"47","author":"ML de Bastos Maximiano","year":"2026","unstructured":"de Bastos Maximiano ML, Goncalves OR, Ribeiro FV, Han ML, de Melo Neto AP, Andrade Fernandes JV, et al. Early versus late anticoagulation treatment after acute ischemic stroke with atrial fibrillation: a meta-analysis of randomized controlled trials. Neurol Sci. 2026;47(3):265. https:\/\/doi.org\/10.1007\/s10072-025-08789-1.","journal-title":"Neurol Sci"},{"issue":"7","key":"1532_CR53","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11239-025-03139-6","volume":"58","author":"V Pereira","year":"2025","unstructured":"Pereira V, Marino M, Hornik A, Hornik J, Henson J, Wesler J, et al. Comparison of early vs late anticoagulation for secondary stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. J Thromb Thrombolysis. 2025;58(7):893\u2013900. https:\/\/doi.org\/10.1007\/s11239-025-03139-6.","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"1532_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.hrthm.2024.12.008","volume":"22","author":"L Fu","year":"2025","unstructured":"Fu L, Hu J, Yang P, Chen Q. Early vs later non-vitamin K antagonist oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation: A meta-analysis and systematic review of randomized trials. Heart Rhythm. 2025;22(3):629\u201336. https:\/\/doi.org\/10.1016\/j.hrthm.2024.12.008.","journal-title":"Heart Rhythm"},{"key":"1532_CR55","doi-asserted-by":"publisher","first-page":"107602962514108","DOI":"10.1177\/10760296251410869","volume":"31","author":"M Moawad","year":"2025","unstructured":"Moawad M, Batarseh S, Awad AA, Amro R, Gadelmawla AF, Kaoud OA, et al. Anticoagulation Timing After Stroke in Atrial Fibrillation: Evidence from a Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost. 2025;31:10760296251410869. https:\/\/doi.org\/10.1177\/10760296251410869.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"1532_CR56","doi-asserted-by":"publisher","first-page":"108159","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108159","volume":"34","author":"OM Al-Janabi","year":"2025","unstructured":"Al-Janabi OM, Odeh A, Gajjar A, Misra A, Mahmood YM, Taha AM, et al. Timing of anticoagulation for patients with atrial fibrillation after acute ischemic stroke: Systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2025;34(1):108159. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.108159.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1532_CR57","doi-asserted-by":"publisher","unstructured":"Dilli Babu A, Singh S, Gorantla A, Ali Baig MF, Bhutani R, Davuluri H, et al. Optimal timing of oral anticoagulation initiation in patients with acute ischaemic stroke and atrial fibrillation: a comprehensive meta-analysis and systematic review. Open Heart. 2024;11(2). https:\/\/doi.org\/10.1136\/openhrt-2024-003002.","DOI":"10.1136\/openhrt-2024-003002"},{"issue":"4","key":"1532_CR58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/23969873241251931","volume":"9","author":"L Palaiodimou","year":"2024","unstructured":"Palaiodimou L, Stefanou MI, Katsanos AH, De Marchis GM, Aguiar De Sousa D, Dawson J, et al. Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis. Eur Stroke J. 2024;9(4):885\u201395. https:\/\/doi.org\/10.1177\/23969873241251931.","journal-title":"Eur Stroke J"},{"issue":"4","key":"1532_CR59","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11239-023-02872-0","volume":"56","author":"M Jiang","year":"2023","unstructured":"Jiang M, Wang C, Zhang Y. Comparison of early and delayed anticoagulation therapy after ischemic stroke in patients with atrial fibrillation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2023;56(4):603\u201313. https:\/\/doi.org\/10.1007\/s11239-023-02872-0.","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"1532_CR60","doi-asserted-by":"publisher","first-page":"108371","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108371","volume":"34","author":"E Uawithya","year":"2025","unstructured":"Uawithya E, Saengphatrachai W, Srisurapanont K, Praditukrit K, Kaveeta C. Early versus delayed direct oral anticoagulant initiation in nonvalvular atrial fibrillation-associated acute ischemic stroke: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2025;34(8):108371. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108371.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10498","key":"1532_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0140-6736(25)00439-8","volume":"406","author":"HM Dehbi","year":"2025","unstructured":"Dehbi HM, Fischer U, Asberg S, Milling TJ, Abend S, Ahmed N, et al. Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST). Lancet. 2025;406(10498):43\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(25)00439-8.","journal-title":"Lancet"},{"issue":"2","key":"1532_CR62","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s10072-026-08818-7","volume":"47","author":"E Spina","year":"2026","unstructured":"Spina E, Romoli M, Mosconi MG, Padroni M, Canavero I, Mannino M, et al. Timing of anticoagulation therapy in patients with acute ischemic stroke and atrial fibrillation: a GRADE-based expert opinion recommendation. Neurol Sci. 2026;47(2):206. https:\/\/doi.org\/10.1007\/s10072-026-08818-7.","journal-title":"Neurol Sci"},{"issue":"8","key":"1532_CR63","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/europace\/euy054","volume":"20","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace. 2018;20(8):1231\u201342. https:\/\/doi.org\/10.1093\/europace\/euy054.","journal-title":"Europace"},{"issue":"38","key":"1532_CR64","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893\u2013962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210.","journal-title":"Eur Heart J"},{"issue":"7","key":"1532_CR65","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2021;52(7):e364\u2013467. https:\/\/doi.org\/10.1161\/STR.0000000000000375.","journal-title":"Stroke"},{"issue":"4","key":"1532_CR66","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/23969873231186863","volume":"8","author":"M Paciaroni","year":"2023","unstructured":"Paciaroni M, Caso V, Romoli M, Becattini C, Salerno A, Rapillo C, et al. Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study. Eur Stroke J. 2023;8(4):1030\u201340. https:\/\/doi.org\/10.1177\/23969873231186863.","journal-title":"Eur Stroke J"},{"issue":"39","key":"1532_CR67","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023;44(39):3948\u20134042. https:\/\/doi.org\/10.1093\/eurheartj\/ehad193.","journal-title":"Eur Heart J"},{"key":"1532_CR68","doi-asserted-by":"publisher","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013227. https:\/\/doi.org\/10.1161\/CIR.0000000000000923.","DOI":"10.1161\/CIR.0000000000000923"},{"issue":"Suppl 1","key":"1532_CR69","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1016\/j.thromres.2021.11.024","volume":"213","author":"O Itzhaki Ben Zadok","year":"2022","unstructured":"Itzhaki Ben Zadok O, Spectre G, Leader A. Cancer-associated non-bacterial thrombotic endocarditis. Thromb Res. 2022;213(Suppl 1):S127\u201332. https:\/\/doi.org\/10.1016\/j.thromres.2021.11.024.","journal-title":"Thromb Res"},{"key":"1532_CR70","doi-asserted-by":"publisher","unstructured":"Foschi M, De Santis F, Gabriele F, D\u2019Anna L, Zini A, Paolucci M, et al. Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study. Eur Stroke J. 2026;11(2). https:\/\/doi.org\/10.1093\/esj\/aakag015.","DOI":"10.1093\/esj\/aakag015"},{"issue":"4","key":"1532_CR71","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/23969873241247978","volume":"9","author":"V Caso","year":"2024","unstructured":"Caso V, Turc G, Abdul-Rahim AH, Castro P, Hussain S, Lal A, et al. European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke. Eur Stroke J. 2024;9(4):800\u201334. https:\/\/doi.org\/10.1177\/23969873241247978.","journal-title":"Eur Stroke J"},{"issue":"15","key":"1532_CR72","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1161\/CIR.0000000000001092","volume":"146","author":"GN Levine","year":"2022","unstructured":"Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, et al. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022;146(15):e205\u201323. https:\/\/doi.org\/10.1161\/CIR.0000000000001092.","journal-title":"Circulation"},{"issue":"9","key":"1532_CR73","doi-asserted-by":"publisher","first-page":"e214758","DOI":"10.1212\/WNL.0000000000214758","volume":"106","author":"M Foschi","year":"2026","unstructured":"Foschi M, De Santis F, Gabriele F, Ornello R, D\u2019Anna L, Zini A, et al. Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation. Neurology. 2026;106(9):e214758. https:\/\/doi.org\/10.1212\/WNL.0000000000214758.","journal-title":"Neurology"},{"issue":"7","key":"1532_CR74","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2022;53(7):e282\u2013361. https:\/\/doi.org\/10.1161\/STR.0000000000000407.","journal-title":"Stroke"},{"issue":"8","key":"1532_CR75","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1177\/17474930251365861","volume":"20","author":"C Cordonnier","year":"2025","unstructured":"Cordonnier C, Klijn C, Smith EE, Al-Shahi Salman R, Chwalisz BK, van Etten E, et al. Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization. Int J Stroke. 2025;20(8):949\u201367. https:\/\/doi.org\/10.1177\/17474930251365861.","journal-title":"Int J Stroke"},{"issue":"6","key":"1532_CR76","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","volume":"17","author":"D Wilson","year":"2018","unstructured":"Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018;17(6):539\u201347. https:\/\/doi.org\/10.1016\/S1474-4422(18)30145-5.","journal-title":"Lancet Neurol"},{"key":"1532_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42466-019-0018-0","volume":"1","author":"JA Sembill","year":"2019","unstructured":"Sembill JA, Kuramatsu JB, Schwab S, Huttner HB. Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage. Neurol Res Pract. 2019;1:12. https:\/\/doi.org\/10.1186\/s42466-019-0018-0.","journal-title":"Neurol Res Pract"},{"issue":"1","key":"1532_CR78","doi-asserted-by":"publisher","first-page":"e03219","DOI":"10.1016\/j.heliyon.2020.e03219","volume":"6","author":"H Budincevic","year":"2020","unstructured":"Budincevic H, Crnac Zuna P, Saleh C, Lange N, Piechowski-Jozwiak B, Bielen I, et al. Antithrombotic therapy in patients with non-traumatic intracerebral haemorrhage and atrial fibrillation: A retrospective study. Heliyon. 2020;6(1):e03219. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03219.","journal-title":"Heliyon"},{"issue":"10","key":"1532_CR79","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","volume":"20","author":"SC So","year":"2021","unstructured":"So SC. Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial. Lancet Neurol. 2021;20(10):842\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(21)00264-7.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1532_CR80","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","volume":"22","author":"R Al-Shahi Salman","year":"2023","unstructured":"Al-Shahi Salman R, Stephen J, Tierney JF, Lewis SC, Newby DE, Parry-Jones AR, et al. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol. 2023;22(12):1140\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(23)00315-0.","journal-title":"Lancet Neurol"},{"issue":"11","key":"1532_CR81","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","volume":"20","author":"F Schreuder","year":"2021","unstructured":"Schreuder F, van Nieuwenhuizen KM, Hofmeijer J, Vermeer SE, Kerkhoff H, Zock E, et al. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial. Lancet Neurol. 2021;20(11):907\u201316. https:\/\/doi.org\/10.1016\/S1474-4422(21)00298-2.","journal-title":"Lancet Neurol"},{"issue":"10482","key":"1532_CR82","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","volume":"405","author":"R Veltkamp","year":"2025","unstructured":"Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fiessler C, Malzahn U, et al. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2025;405(10482):927\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(25)00333-2.","journal-title":"Lancet"},{"issue":"6","key":"1532_CR83","doi-asserted-by":"publisher","first-page":"e041301","DOI":"10.1161\/JAHA.125.041301","volume":"15","author":"A Sakusic","year":"2026","unstructured":"Sakusic A, Ghozy S, Verma Y, Elgazzar T, Rabinstein AA, Braksick SA, et al. Resumption of Warfarin After Intracranial Hemorrhage in Patients With Mechanical Heart Valves: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2026;15(6):e041301. https:\/\/doi.org\/10.1161\/JAHA.125.041301.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"1532_CR84","doi-asserted-by":"publisher","first-page":"e214184","DOI":"10.1212\/WNL.0000000000214184","volume":"105","author":"L D\u2019Anna","year":"2025","unstructured":"D\u2019Anna L, Prandin G, Pirera E, Sacco S, Veltkamp R, Korompoki E, et al. Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves: A Meta-Analysis. Neurology. 2025;105(8):e214184. https:\/\/doi.org\/10.1212\/WNL.0000000000214184.","journal-title":"Neurology"},{"issue":"19","key":"1532_CR85","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/eurheartj\/ehy056","volume":"39","author":"JB Kuramatsu","year":"2018","unstructured":"Kuramatsu JB, Sembill JA, Gerner ST, Sprugel MI, Hagen M, Roeder SS, et al. Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J. 2018;39(19):1709\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/ehy056.","journal-title":"Eur Heart J"},{"issue":"15","key":"1532_CR86","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJMoa2513880","volume":"394","author":"M Sharma","year":"2026","unstructured":"Sharma M, Dong Q, Hirano T, Kasner SE, Saver JL, Masjuan J, et al. Asundexian for Secondary Stroke Prevention. N Engl J Med. 2026;394(15):1467\u201379. https:\/\/doi.org\/10.1056\/NEJMoa2513880.","journal-title":"N Engl J Med"},{"issue":"3","key":"1532_CR87","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","volume":"13","author":"JE Nielsen-Kudsk","year":"2017","unstructured":"Nielsen-Kudsk JE, Johnsen SP, Wester P, Damgaard D, Airaksinen J, Lund J, et al. Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study. EuroIntervention. 2017;13(3):371\u20138. https:\/\/doi.org\/10.4244\/EIJ-D-17-00201.","journal-title":"EuroIntervention"},{"issue":"2","key":"1532_CR88","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/17474930251364082","volume":"21","author":"R Mikulik","year":"2026","unstructured":"Mikulik R, Neto G, Sedani R, Ameriso SF, Mammadova N, Marchenko S, et al. Differences in acute ischemic stroke treatment: A cross-sectional study from international Registry of Stroke Care Quality (RES-Q). Int J Stroke. 2026;21(2):188\u201399. https:\/\/doi.org\/10.1177\/17474930251364082.","journal-title":"Int J Stroke"},{"key":"1532_CR89","doi-asserted-by":"publisher","unstructured":"Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, et al. 2025 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2025;67(8). https:\/\/doi.org\/10.1093\/ejcts\/ezaf276.","DOI":"10.1093\/ejcts\/ezaf276"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01532-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01532-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01532-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:56:32Z","timestamp":1792652192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01532-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1532"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01532-z","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"22 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.B. declares speaker\u2019s fees from Bayer, Boehringer Ingelheim, Viatris, Novartis, Pliva-Teva, Abbott, Medis, Eli Lilly, Berlin Chemie, Pfizer, and Roche. Other authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"61"}}